Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Bradley Corr

Concepts (165)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
9
2023
141
3.160
Why?
Ovarian Neoplasms
7
2022
386
1.960
Why?
Carcinoma, Endometrioid
3
2022
46
1.930
Why?
beta Catenin
4
2023
218
1.440
Why?
Lymph Nodes
2
2018
415
0.950
Why?
Wnt Signaling Pathway
2
2021
146
0.830
Why?
Uterine Cervical Neoplasms
5
2023
213
0.720
Why?
Wnt Proteins
1
2021
134
0.690
Why?
Mutation
5
2023
3338
0.670
Why?
Adenocarcinoma, Mucinous
1
2018
61
0.560
Why?
Gynecologic Surgical Procedures
2
2020
44
0.540
Why?
Venous Thromboembolism
2
2020
230
0.530
Why?
Cisplatin
2
2023
262
0.510
Why?
Neoplasms, Glandular and Epithelial
1
2015
34
0.500
Why?
Keratin-5
1
2015
46
0.500
Why?
Tumor Suppressor Protein p53
4
2023
445
0.490
Why?
Neoplasm Recurrence, Local
2
2023
850
0.480
Why?
Hysterectomy
4
2019
105
0.470
Why?
Antineoplastic Agents
4
2023
1875
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2023
1356
0.440
Why?
Bile Ducts, Intrahepatic
1
2013
48
0.440
Why?
Cholangiocarcinoma
1
2013
38
0.430
Why?
Bile Duct Neoplasms
1
2013
56
0.430
Why?
Genital Neoplasms, Female
3
2024
70
0.390
Why?
Lymph Node Excision
3
2018
140
0.380
Why?
Neoplasm Grading
3
2022
241
0.370
Why?
Biomarkers, Tumor
4
2023
1032
0.350
Why?
Female
27
2024
59325
0.330
Why?
Middle Aged
17
2023
26605
0.280
Why?
Aged, 80 and over
11
2023
6306
0.260
Why?
Immunohistochemistry
2
2023
1624
0.260
Why?
Cell Survival
2
2021
1014
0.250
Why?
Humans
29
2024
114043
0.240
Why?
Cell Line, Tumor
3
2021
2698
0.220
Why?
Neoplasms
3
2022
2086
0.220
Why?
Bevacizumab
2
2022
114
0.220
Why?
Poly-ADP-Ribose Binding Proteins
2
2023
31
0.220
Why?
DNA Polymerase II
2
2023
37
0.220
Why?
Tertiary Care Centers
1
2023
126
0.210
Why?
Fallopian Tube Neoplasms
1
2022
14
0.200
Why?
Aged
13
2023
18969
0.200
Why?
Camptothecin
1
2022
96
0.190
Why?
Thrombocytopenia
1
2023
177
0.190
Why?
Heterocyclic Compounds, 3-Ring
1
2021
28
0.190
Why?
Retrospective Studies
6
2022
12521
0.190
Why?
Indazoles
1
2021
57
0.180
Why?
Neoplasm Staging
3
2019
1162
0.180
Why?
High-Throughput Nucleotide Sequencing
1
2023
437
0.180
Why?
Clinical Trials, Phase I as Topic
1
2020
45
0.180
Why?
Benzoxazoles
1
2020
16
0.170
Why?
Imidazoles
1
2021
203
0.170
Why?
Azepines
1
2020
69
0.170
Why?
Mindfulness
1
2021
98
0.170
Why?
Enoxaparin
1
2020
52
0.170
Why?
Disease Susceptibility
1
2021
316
0.160
Why?
Pyridones
1
2020
122
0.160
Why?
Microsatellite Instability
1
2019
32
0.160
Why?
Survival Analysis
3
2020
1206
0.160
Why?
Margins of Excision
1
2019
29
0.160
Why?
Gene Expression Regulation, Neoplastic
2
2021
1142
0.160
Why?
Drug Resistance, Neoplasm
3
2020
636
0.160
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
76
0.160
Why?
Cross-Sectional Studies
3
2018
4402
0.160
Why?
Adult
12
2023
30375
0.160
Why?
Molecular Targeted Therapy
1
2021
347
0.150
Why?
Protein Kinase Inhibitors
2
2023
784
0.150
Why?
Recurrence
1
2021
925
0.150
Why?
Oncologists
1
2018
30
0.150
Why?
PTEN Phosphohydrolase
1
2019
140
0.150
Why?
Frozen Sections
1
2018
24
0.150
Why?
Pyridines
1
2021
419
0.150
Why?
Preoperative Care
2
2017
319
0.150
Why?
Disease Management
1
2021
556
0.140
Why?
Pyrimidines
1
2020
374
0.140
Why?
Pyrazoles
1
2020
361
0.140
Why?
Minority Groups
1
2018
223
0.140
Why?
Amyotrophic Lateral Sclerosis
3
2003
60
0.130
Why?
Antibodies, Monoclonal, Humanized
1
2020
660
0.130
Why?
Anticoagulants
1
2020
547
0.130
Why?
Gynecology
1
2018
163
0.130
Why?
Tissue Array Analysis
1
2015
48
0.130
Why?
Neoplasm Invasiveness
1
2017
438
0.120
Why?
Perioperative Period
1
2015
47
0.120
Why?
Radiography, Thoracic
1
2016
150
0.120
Why?
Surgeons
1
2018
236
0.120
Why?
Laparotomy
1
2015
101
0.120
Why?
Treatment Outcome
3
2020
9049
0.120
Why?
Heparin
1
2015
225
0.110
Why?
Quality of Health Care
1
2018
572
0.110
Why?
Robotic Surgical Procedures
1
2015
86
0.110
Why?
Membrane Proteins
1
2019
1016
0.110
Why?
Receptors, Estrogen
1
2015
371
0.100
Why?
Postoperative Complications
2
2020
2122
0.100
Why?
Breast Neoplasms
1
2024
1846
0.100
Why?
Prognosis
5
2023
3315
0.100
Why?
Combined Modality Therapy
2
2013
1117
0.100
Why?
Ovary
1
2013
190
0.100
Why?
Case-Control Studies
1
2019
3003
0.100
Why?
Prospective Studies
4
2023
6195
0.090
Why?
Maximum Tolerated Dose
2
2022
183
0.090
Why?
Cohort Studies
2
2023
4883
0.090
Why?
Immunotherapy
1
2012
473
0.080
Why?
Cell Proliferation
1
2015
2173
0.080
Why?
Apoptosis
1
2015
2349
0.070
Why?
Young Adult
4
2021
10444
0.060
Why?
Carbonyl Reductase (NADPH)
1
2024
4
0.060
Why?
Wnt4 Protein
1
2024
17
0.060
Why?
DNA Mismatch Repair
1
2023
37
0.050
Why?
Registries
3
2018
1764
0.050
Why?
Lung Neoplasms
1
2016
2159
0.050
Why?
Mesylates
1
2022
7
0.050
Why?
Topoisomerase I Inhibitors
1
2022
15
0.050
Why?
AMP-Activated Protein Kinases
1
2024
170
0.050
Why?
Platinum
1
2022
38
0.050
Why?
Ligands
1
2024
557
0.050
Why?
Adolescent
4
2021
17800
0.050
Why?
Antibodies, Bispecific
1
2022
32
0.050
Why?
Ambulatory Care Facilities
1
2003
212
0.050
Why?
Paclitaxel
1
2022
190
0.050
Why?
Decision Trees
1
2000
82
0.040
Why?
Aurora Kinase A
1
2020
51
0.040
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
55
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
97
0.040
Why?
Vascular Endothelial Growth Factor A
1
2022
496
0.040
Why?
Tumor Microenvironment
1
2022
428
0.040
Why?
Patient Care Team
1
2003
517
0.040
Why?
Neoplasm Metastasis
1
2020
521
0.040
Why?
Xenograft Model Antitumor Assays
1
2020
695
0.040
Why?
Ireland
3
2003
24
0.040
Why?
Program Evaluation
1
2021
820
0.040
Why?
Chemoradiotherapy
1
2018
187
0.040
Why?
Disease Progression
2
2020
2371
0.030
Why?
Neoadjuvant Therapy
1
2018
305
0.030
Why?
Regression Analysis
1
2019
945
0.030
Why?
RNA
1
2022
807
0.030
Why?
Ileus
1
2015
10
0.030
Why?
Salpingectomy
1
2015
13
0.030
Why?
Caregivers
1
2021
713
0.030
Why?
Urinary Retention
1
2015
19
0.030
Why?
Survival Rate
1
2019
1638
0.030
Why?
Ovariectomy
1
2015
116
0.030
Why?
Blood Loss, Surgical
1
2015
82
0.030
Why?
Pelvis
1
2015
89
0.030
Why?
Referral and Consultation
1
2018
632
0.030
Why?
Pandemics
1
2021
1310
0.030
Why?
Logistic Models
1
2018
1829
0.030
Why?
Follow-Up Studies
2
2018
4392
0.030
Why?
Patient Readmission
1
2018
607
0.030
Why?
United States
2
2019
12137
0.030
Why?
Signal Transduction
1
2024
4501
0.020
Why?
Immunotherapy, Adoptive
1
2012
184
0.020
Why?
Length of Stay
1
2015
957
0.020
Why?
Practice Patterns, Physicians'
1
2018
1175
0.020
Why?
Quality of Life
1
2020
2343
0.020
Why?
Patient Discharge
1
2015
770
0.020
Why?
Age Factors
1
2015
2885
0.020
Why?
Diagnosis, Differential
2
2003
1331
0.020
Why?
Antibodies, Monoclonal
1
2012
1257
0.020
Why?
Mice
1
2020
14841
0.010
Why?
Male
4
2020
55396
0.010
Why?
Interprofessional Relations
1
2003
246
0.010
Why?
Central Nervous System Diseases
1
2000
60
0.010
Why?
Animals
1
2020
31565
0.010
Why?
Age of Onset
1
2000
444
0.010
Why?
Palliative Care
1
2003
641
0.010
Why?
Corr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)